Literature DB >> 25868149

Correlations between mini-mental state examination score, cerebrospinal fluid biomarkers, and pathology observed in brain biopsies of patients with normal-pressure hydrocephalus.

Adila Elobeid1, Katarina Laurell, Kristina Giuliana Cesarini, Irina Alafuzoff.   

Abstract

Alzheimer disease (AD)-related pathology was assessed in cortical biopsy samples of 111 patients with idiopathic normal-pressure hydrocephalus. Alzheimer disease hallmark lesions-β-amyloid (Aβ) and hyperphosphorylated tau (HPtau)-were observed in 47% of subjects, a percentage consistent with that for whole-brain assessment reported postmortem in unselected cohorts. Higher-immunostained area fraction of AD pathology corresponded with lower preoperative mini-mental state examination scores. Concomitant Aβ and HPtau pathology, reminiscent of that observed in patients with AD, was observed in 22% of study subjects. There was a significant correlation between Aβ-immunostained area fraction in tissue and Aβ42 (42-amino-acid form of Aβ) in cerebrospinal fluid (CSF). Levels of Aβ42 were significantly lower in CSF in subjects with concomitant Aβ and HPtau pathology compared with subjects lacking pathology. Moreover, a significant correlation between HPtau-immunostained area fraction and HPtau in CSF was noted. Both HPtau and total tau were significantly higher in CSF in subjects with concomitant Aβ and HPtau pathology compared with subjects lacking pathology. The 42-amino-acid form of Aβ (Aβ42) and HPtau in CSF were the most significant predictors of the presence of AD pathology in cortical biopsies. Long-term follow-up studies are warranted to assess whether all patients with idiopathic normal-pressure hydrocephalus with AD pathology progress to AD and to determine the pathologic substrate of idiopathic normal-pressure hydrocephalus.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25868149     DOI: 10.1097/NEN.0000000000000191

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  16 in total

1.  Cerebrospinal fluid dynamics and discordant amyloid biomarkers.

Authors:  Jonathan Graff-Radford; David T Jones; Heather J Wiste; Petrice M Cogswell; Stephen D Weigand; Val Lowe; Benjamin D Elder; Prashanthi Vemuri; Argonde Van Harten; Michelle M Mielke; David S Knopman; Neill R Graff-Radford; Ronald C Petersen; Clifford R Jack; Jeffrey L Gunter
Journal:  Neurobiol Aging       Date:  2021-11-01       Impact factor: 4.673

2.  Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases.

Authors:  Geidy E Serrano; Anthony Intorcia; Jeremiah Carew; Glenn Chiarolanza; Jose A Hidalgo; Lucia I Sue; Brittany N Dugger; Megan Saxon-LaBelle; Jessica Filon; Alex Scroggins; Joel Pullen; Brandon E Fornwalt; Sarah Scott; Marwan N Sabbagh; Charles H Adler; Haruhiko Akiyama; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

3.  Brain comorbidities in normal pressure hydrocephalus.

Authors:  G Allali; M Laidet; S Armand; F Assal
Journal:  Eur J Neurol       Date:  2018-01-13       Impact factor: 6.089

4.  Decreased Expression of hsa-miR-4274 in Cerebrospinal Fluid of Normal Pressure Hydrocephalus Mimics with Parkinsonian Syndromes.

Authors:  Ivana Jurjević; Masakazu Miyajima; Ikuko Ogino; Chihiro Akiba; Madoka Nakajima; Akihide Kondo; Mika Kikkawa; Mitsuyasu Kanai; Nobutaka Hattori; Hajime Arai
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Alzheimer's disease neuropathological change and loss of matrix/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer's disease.

Authors:  Sylwia Libard; Irina Alafuzoff
Journal:  Acta Neuropathol Commun       Date:  2019-05-29       Impact factor: 7.801

6.  Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia.

Authors:  Thomas G Beach; Charles H Adler; Nan Zhang; Geidy E Serrano; Lucia I Sue; Erika Driver-Dunckley; Shayamal H Mehta; Edouard E Zamrini; Marwan N Sabbagh; Holly A Shill; Christine M Belden; David R Shprecher; Richard J Caselli; Eric M Reiman; Kathryn J Davis; Kathy E Long; Lisa R Nicholson; Anthony J Intorcia; Michael J Glass; Jessica E Walker; Michael M Callan; Javon C Oliver; Richard Arce; Richard C Gerkin
Journal:  PLoS One       Date:  2020-04-22       Impact factor: 3.240

7.  Pathological mitochondria in neurons and perivascular astrocytic endfeet of idiopathic normal pressure hydrocephalus patients.

Authors:  Md Mahdi Hasan-Olive; Rune Enger; Hans-Arne Hansson; Erlend A Nagelhus; Per Kristian Eide
Journal:  Fluids Barriers CNS       Date:  2019-12-18

8.  Protein tyrosine phosphatase receptor type Q in cerebrospinal fluid reflects ependymal cell dysfunction and is a potential biomarker for adult chronic hydrocephalus.

Authors:  M Nakajima; T Rauramaa; P M Mäkinen; M Hiltunen; S-K Herukka; M Kokki; T Musialowicz; H-K Jyrkkänen; N Danner; A Junkkari; A M Koivisto; J E Jääskeläinen; M Miyajima; I Ogino; A Furuta; C Akiba; K Kawamura; C Kamohara; H Sugano; Y Tange; K Karagiozov; V Leinonen; H Arai
Journal:  Eur J Neurol       Date:  2020-11-01       Impact factor: 6.089

9.  Proteomic differences between focal and diffuse traumatic brain injury in human brain tissue.

Authors:  Sami Abu Hamdeh; Ganna Shevchenko; Jia Mi; Sravani Musunuri; Jonas Bergquist; Niklas Marklund
Journal:  Sci Rep       Date:  2018-05-01       Impact factor: 4.379

10.  Change of Amyloid-β 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus.

Authors:  Chihiro Akiba; Madoka Nakajima; Masakazu Miyajima; Ikuko Ogino; Yumiko Motoi; Kaito Kawamura; Satoshi Adachi; Akihide Kondo; Hidenori Sugano; Takahiko Tokuda; Kazuhiro Irie; Hajime Arai
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.